Antibiotic-Induced Changes in Microbiome-Related Metabolites and Bile Acids in Rat Plasma.

antibiotics bile acids metabolomics microbiome

Journal

Metabolites
ISSN: 2218-1989
Titre abrégé: Metabolites
Pays: Switzerland
ID NLM: 101578790

Informations de publication

Date de publication:
11 Jun 2020
Historique:
received: 16 04 2020
revised: 30 05 2020
accepted: 04 06 2020
entrez: 18 6 2020
pubmed: 18 6 2020
medline: 18 6 2020
Statut: epublish

Résumé

Various environmental factors can alter the gut microbiome's composition and functionality, and modulate host health. In this study, the effects of oral and parenteral administration of two poorly bioavailable antibiotics (i.e., vancomycin and streptomycin) on male Wistar Crl/Wi(Han) rats for 28 days were compared to distinguish between microbiome-derived or -associated and systemic changes in the plasma metabolome. The resulting changes in the plasma metabolome were compared to the effects of a third reference compound, roxithromycin, which is readily bioavailable. A community analysis revealed that the oral administration of vancomycin and roxithromycin in particular leads to an altered microbial population. Antibiotic-induced changes depending on the administration routes were observed in plasma metabolite levels. Indole-3-acetic acid (IAA) and hippuric acid (HA) were identified as key metabolites of microbiome modulation, with HA being the most sensitive. Even though large variations in the plasma bile acid pool between and within rats were observed, the change in microbiome community was observed to alter the composition of the bile acid pool, especially by an accumulation of taurine-conjugated primary bile acids. In-depth investigation of the relationship between microbiome variability and their functionality, with emphasis on the bile acid pool, will be necessary to better assess the potential adverseness of environmentally induced microbiome changes.

Identifiants

pubmed: 32545183
pii: metabo10060242
doi: 10.3390/metabo10060242
pmc: PMC7344402
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Toxicol Lett. 2007 Jul 30;172(1-2):21-8
pubmed: 17614222
Int J Mol Sci. 2015 Apr 02;16(4):7493-519
pubmed: 25849657
Br J Pharmacol Chemother. 1961 Dec;17:420-3
pubmed: 13904908
Am J Kidney Dis. 2016 Mar;67(3):483-98
pubmed: 26590448
Clin Pharmacokinet. 2012 Jan 1;51(1):1-13
pubmed: 22149255
Nature. 2007 Oct 18;449(7164):804-10
pubmed: 17943116
J Lipid Res. 2009 Oct;50(10):1955-66
pubmed: 19346330
Int J Obes (Lond). 2010 Jun;34(6):1095-8
pubmed: 20212498
Proc Staff Meet Mayo Clin. 1956 Oct 17;31(21):564-82
pubmed: 13370625
Xenobiotica. 2002 Sep;32(9):783-94
pubmed: 12396275
J Proteome Res. 2011 Dec 2;10(12):5512-22
pubmed: 21970572
Proc Natl Acad Sci U S A. 2006 Mar 7;103(10):3920-5
pubmed: 16473946
Proc Natl Acad Sci U S A. 2009 Mar 10;106(10):3698-703
pubmed: 19234110
Mutat Res. 2012 Aug 15;746(2):144-50
pubmed: 22305969
Int J Tryptophan Res. 2019 Mar 28;12:1178646919834550
pubmed: 30944520
Proc Natl Acad Sci U S A. 2003 Sep 2;100(18):10452-9
pubmed: 12923294
Nat Methods. 2016 Jul;13(7):581-3
pubmed: 27214047
Drug Metab Dispos. 1995 Feb;23(2):255-60
pubmed: 7736921
Appl Environ Microbiol. 2006 Mar;72(3):1729-38
pubmed: 16517616
Toxicology. 2017 Jul 1;386:1-10
pubmed: 28529062
Biopharm Drug Dispos. 1998 Oct;19(7):433-8
pubmed: 9818709
Plant J. 2000 Jul;23(1):131-42
pubmed: 10929108
Appl Microbiol Biotechnol. 2017 Jan;101(1):47-64
pubmed: 27888332
Cell Host Microbe. 2016 Dec 14;20(6):709-715
pubmed: 27916477
Toxicol Appl Pharmacol. 2019 Jan 15;363:79-87
pubmed: 30502395
Proc Natl Acad Sci U S A. 2011 Mar 15;108 Suppl 1:4523-30
pubmed: 20837534
Arch Toxicol. 2017 Oct;91(10):3439-3454
pubmed: 28337503
J Lipid Res. 2006 Feb;47(2):241-59
pubmed: 16299351
Plant Cell. 1995 Jul;7(7):907-919
pubmed: 12242393
J Vet Pharmacol Ther. 1991 Mar;14(1):1-35
pubmed: 2038090
Liver Res. 2019 May 21;3(2):88-98
pubmed: 32015930
Eur J Pharm Sci. 2014 Jun 16;57:280-91
pubmed: 23988844
Nat Commun. 2019 Oct 3;10(1):4505
pubmed: 31582752
Am J Physiol. 1990 May;258(5 Pt 1):G653-9
pubmed: 2159238
Biomarkers. 2004 Jan-Feb;9(1):1-31
pubmed: 15204308
Metabolism. 2011 Mar;60(3):404-13
pubmed: 20423748
Mol Genet Metab. 2015 Mar;114(3):431-7
pubmed: 25680927
Expert Opin Drug Metab Toxicol. 2018 Jan;14(1):59-82
pubmed: 29226732
Gastroenterology. 2005 Nov;129(5):1445-53
pubmed: 16285946
Nat Rev Gastroenterol Hepatol. 2018 Feb;15(2):111-128
pubmed: 29018272
J Bacteriol. 1972 Jan;109(1):74-80
pubmed: 4550677
Toxicol Lett. 2010 Oct 5;198(2):159-70
pubmed: 20600714
Aliment Pharmacol Ther. 2018 Apr;47(8):1054-1070
pubmed: 29460487
Liver Res. 2017 Jun;1(1):3-9
pubmed: 29104811
J Am Soc Nephrol. 2015 Apr;26(4):876-87
pubmed: 25145928
J Biol Chem. 1990 Jun 15;265(17):10036-41
pubmed: 1693613
Nat Methods. 2010 May;7(5):335-6
pubmed: 20383131
J Proteome Res. 2013 Apr 5;12(4):1527-46
pubmed: 23342949
Cell Metab. 2015 Aug 4;22(2):320-31
pubmed: 26244934
Gastroenterology. 2009 May;136(6):2015-31
pubmed: 19462507
Trends Pharmacol Sci. 2009 Nov;30(11):570-80
pubmed: 19758712
Cell Rep. 2016 Feb 9;14(5):1049-1061
pubmed: 26832403
Kidney Int. 2002 May;61(5):1760-8
pubmed: 11967025
ALTEX. 2013;30(2):209-25
pubmed: 23665807
Antimicrob Agents Chemother. 2004 Nov;48(11):4427-9
pubmed: 15504873
Clin Chem. 2014 Feb;60(2):399-412
pubmed: 24305685
J Toxicol Environ Health A. 2018;81(11):408-420
pubmed: 29608440
J Pharm Sci. 1971 Feb;60(2):278-81
pubmed: 5572455
Biol Chem. 2003 May;384(5):711-9
pubmed: 12817467

Auteurs

Véronique de Bruijn (V)

BASF SE, Experimental Toxicology and Ecology, 67056 Ludwigshafen, Germany.
Division of Toxicology, Wageningen University and Research, 6708 WE Wageningen, The Netherlands.

Christina Behr (C)

BASF SE, Experimental Toxicology and Ecology, 67056 Ludwigshafen, Germany.

Saskia Sperber (S)

BASF SE, Experimental Toxicology and Ecology, 67056 Ludwigshafen, Germany.

Tilmann Walk (T)

BASF Metabolome Solutions, Tegeler Weg 33, 10589 Berlin, Germany.

Philipp Ternes (P)

BASF Metabolome Solutions, Tegeler Weg 33, 10589 Berlin, Germany.

Markus Slopianka (M)

BASF Metabolome Solutions, Tegeler Weg 33, 10589 Berlin, Germany.

Volker Haake (V)

BASF Metabolome Solutions, Tegeler Weg 33, 10589 Berlin, Germany.

Karsten Beekmann (K)

Division of Toxicology, Wageningen University and Research, 6708 WE Wageningen, The Netherlands.

Bennard van Ravenzwaay (B)

BASF SE, Experimental Toxicology and Ecology, 67056 Ludwigshafen, Germany.

Classifications MeSH